Effects of Omega-۳ Supplementation on Blood Pressure in Patients with Type ۲ Diabetes: A Double-Blind, Placebo-Controlled Clinical Trial
محل انتشار: مجله دیابت و چاقی ایران، دوره: 5، شماره: 2
سال انتشار: 1392
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 86
فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJDO-5-2_002
تاریخ نمایه سازی: 16 آبان 1402
چکیده مقاله:
Objective: Type ۲ diabetes mellitus (DM-۲) is a chronic and progressive metabolic disorder known as a serious threatening condition in the individual and society. Type ۲ diabetes mellitus is known as the major cause of cardiovascular diseases (CVD). Contradictory evidences about the effect of omega-۳ fatty acids on CVD risk factors, particularly hypertension. The aim of this study was to determine the effect of omega-۳fatty acids supplementation on blood pressure in DM-۲ patients.
Materials and Methods: This is a double-blind, placebo-controlled clinical trial on patients referred to Yazd Diabetes Research Center. Seventy DM-۲ patients were randomly assigned to receive either ۲ g/day omega-۳ soft gels (OG) or ۲ g/day placebo (PG) for ۶ weeks. At the beginning and end of the study, blood pressure was measured and compaired
Results: Fifty nine percepts of patients in OG and ۴۱% in PG had hypertension. Initially, there was no significant difference in the mean of age, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP) and duration of diabetes between two groups. At the end of the study, the mean of SBP, DBP and differences between groups were not significant.
Conclusion: Consumption of ۲ g/day omega-۳ supplement for۶ weeks has no significant effect on systolic and diastolic blood pressure in DM-۲ patients.
کلیدواژه ها:
نویسندگان
Faezeh Poursoleiman
MSc student, Department of Nutrition, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Hassan Mozaffari-Khosravi
Department of Nutrition, Faculty of Health, Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Javad Zavar Reza
Department of Clinical Biochemistry, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Ali Dehghani
Department of Biostatistics and Epidemiology, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran